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Background: Beta blockers (BB) have been shown to improve cardiac function. However, clinical response to BB therapy displays individual and 
ethnic variation. We examined the effects of BB on left ventricular remodeling among African Americans (AA), Hispanics and Caucasians with systolic 
heart failure
Methods:  170 AA, 186 Hispanics and 62 Caucasians with EF ≤ 40% from any etiology were selected retrospectively. Change in left ventricular 
ejection fraction (LVEF), left ventricular end diastolic dimensions (LVEDD), and degree of mitral regurgitation (MR) in response to 1 year of BB was 
evaluated retrospectively. A non-responder was defined as having an improvement of <5% of the LVEF after one year of BB therapy.
Results:  Overall, an improvement in LVEF was noted among all ethnicities (p<0.001). However, 184 patients (44%) were non responders. 
Caucasians exhibited an improvement in LVEDD (-2.19 ± 4.46, p<0.001) while AA revealed no change and Hispanics displayed worsening LVEDD 
(2.72 ± 4.73 mm, p <0.001) (table 1). There was a significant improvement in degree of MR among Caucasians (p=0.023), while AA and Hispanics 
did not demonstrate any improvement.
Conclusions: The majority of patients demonstrated improvement of LVEF. However, there seems to be ethnic variability in the effects of BB on 
cardiac remodeling. Degree of MR and LVEDD failed to show improvement among AA and Hispanics after one year of BB.
Effects of BB on parameters of cardiac remodeling in AA, Hispanics and Caucasian patients with HF
Caucasians (n=62) African Americans (n=170) Hispanics (n=186) p value
LVEF baseline (in EF%Unit) 31.09±7.82 30.43±6.83 30.54±7.70 0.830
LVEF after 1 year of BB 37.38±9.60 35.43±9.46 35.95±9.76 0.393
Mean change in EF 6.29 ± 9.31 *** 5.00 ± 8.39 *** 5.40 ± 8.21 *** 0.658
LVEDD baseline (mm) 62.87 ±6.69 62.88 ±8.51 58.95±8.37 <0.001
LVEDD after 1 year of BB (mm) 60.67 ±6.73 62.9 ± 8.40 61.68±8.42 0.115
Mean change in LVEDD -2.19 ± 4.46 *** 0.10 ±4.45 2.72 ±4.73 *** 0.082
Degree of Mitral Regurgitation (MR) at Baseline 2.29± 0.98 1.82 ± 1.11 1.62 ±1.06 <0.001
Degree of MR after 1 year 1.98 ± 0.83 * 1.83 ± 1.15 1.80 ± 0.91 ** 0.233
Non Responders (<5% LVEF increase) 27 (43.54%) 76 (44.70%) 86 (46.24%) 0.650
* p<0.05 vs baseline , ** p <0.01 vs baseline , *** p<0.001 vs baseline
